Bayer’s pharma growth strategy progressing well as pipeline advances
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Marks remarkable acceleration in innovation using AI technology
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Subscribe To Our Newsletter & Stay Updated